DCGI gives nod for 'restricted emergency' use of Itolizumab injection on COVID-19 patients
Biocon has presented the Phase II clinical trial results generated in COVID-19 patients to DCGI.
Jul 11, 2020, 12:56 PM IST
Itolizumab injection
Biocon has presented the Phase II clinical trial results generated in COVID-19 patients to DCGI.
Jul 11, 2020, 12:56 PM IST